PortfoliosLab logoPortfoliosLab logo
RGC vs. DFDV
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

RGC vs. DFDV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regencell Bioscience Holdings Limited (RGC) and DeFi Development Corp (DFDV). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

RGC vs. DFDV - Yearly Performance Comparison


2026 (YTD)202520242023
RGC
Regencell Bioscience Holdings Limited
21.10%16,053.85%-52.95%-35.56%
DFDV
DeFi Development Corp
-34.85%700.93%-41.08%-73.04%

Fundamentals

EPS

RGC:

-$0.01

DFDV:

$2.77

Total Revenue (TTM)

RGC:

$0.00

DFDV:

$7.53M

Gross Profit (TTM)

RGC:

$0.00

DFDV:

$7.40M

EBITDA (TTM)

RGC:

-$4.66M

DFDV:

$93.57M

Returns By Period

In the year-to-date period, RGC achieves a 21.10% return, which is significantly higher than DFDV's -34.85% return.


RGC

1D
9.00%
1M
-3.05%
YTD
21.10%
6M
64.60%
1Y
2,931.18%
3Y*
234.24%
5Y*
10Y*

DFDV

1D
-5.19%
1M
-5.46%
YTD
-34.85%
6M
-76.36%
1Y
406.66%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RGC vs. DFDV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RGC
RGC Risk / Return Rank: 9999
Overall Rank
RGC Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
RGC Sortino Ratio Rank: 9999
Sortino Ratio Rank
RGC Omega Ratio Rank: 9999
Omega Ratio Rank
RGC Calmar Ratio Rank: 100100
Calmar Ratio Rank
RGC Martin Ratio Rank: 100100
Martin Ratio Rank

DFDV
DFDV Risk / Return Rank: 8585
Overall Rank
DFDV Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
DFDV Sortino Ratio Rank: 100100
Sortino Ratio Rank
DFDV Omega Ratio Rank: 9999
Omega Ratio Rank
DFDV Calmar Ratio Rank: 9090
Calmar Ratio Rank
DFDV Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RGC vs. DFDV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regencell Bioscience Holdings Limited (RGC) and DeFi Development Corp (DFDV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RGCDFDVDifference

Sharpe ratio

Return per unit of total volatility

7.76

0.47

+7.28

Sortino ratio

Return per unit of downside risk

6.67

8.72

-2.05

Omega ratio

Gain probability vs. loss probability

1.84

1.94

-0.09

Calmar ratio

Return relative to maximum drawdown

42.26

3.91

+38.35

Martin ratio

Return relative to average drawdown

54.68

5.40

+49.28

RGC vs. DFDV - Sharpe Ratio Comparison

The current RGC Sharpe Ratio is 7.76, which is higher than the DFDV Sharpe Ratio of 0.47. The chart below compares the historical Sharpe Ratios of RGC and DFDV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


RGCDFDVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

7.76

0.47

+7.28

Sharpe Ratio (All Time)

Calculated using the full available price history

0.52

-0.01

+0.53

Correlation

The correlation between RGC and DFDV is 0.01, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

RGC vs. DFDV - Dividend Comparison

Neither RGC nor DFDV has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

RGC vs. DFDV - Drawdown Comparison

The maximum RGC drawdown since its inception was -93.09%, roughly equal to the maximum DFDV drawdown of -92.25%. Use the drawdown chart below to compare losses from any high point for RGC and DFDV.


Loading graphics...

Drawdown Indicators


RGCDFDVDifference

Max Drawdown

Largest peak-to-trough decline

-93.09%

-92.25%

-0.84%

Max Drawdown (1Y)

Largest decline over 1 year

-86.72%

-92.25%

+5.53%

Current Drawdown

Current decline from peak

-67.40%

-91.48%

+24.08%

Average Drawdown

Average peak-to-trough decline

-59.11%

-70.99%

+11.88%

Ulcer Index

Depth and duration of drawdowns from previous peaks

67.02%

66.83%

+0.19%

Volatility

RGC vs. DFDV - Volatility Comparison

The current volatility for Regencell Bioscience Holdings Limited (RGC) is 28.69%, while DeFi Development Corp (DFDV) has a volatility of 35.71%. This indicates that RGC experiences smaller price fluctuations and is considered to be less risky than DFDV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


RGCDFDVDifference

Volatility (1M)

Calculated over the trailing 1-month period

28.69%

35.71%

-7.02%

Volatility (6M)

Calculated over the trailing 6-month period

108.39%

89.03%

+19.36%

Volatility (1Y)

Calculated over the trailing 1-year period

383.81%

865.60%

-481.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

313.90%

537.08%

-223.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

313.90%

537.08%

-223.18%

Financials

RGC vs. DFDV - Financials Comparison

This section allows you to compare key financial metrics between Regencell Bioscience Holdings Limited and DeFi Development Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-2.00B-1.50B-1.00B-500.00M0.002021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJuly0
4.63M
(RGC) Total Revenue
(DFDV) Total Revenue
Values in USD except per share items